India vs Uzbekistan: Treatment success rate: XDR-TB cases
India
73
in 2022
Uzbekistan
71
in 2021
India rank
33rd
Uzbekistan rank
35th
Treatment success rate: XDR-TB cases over time
- India
- Uzbekistan
How they compare
India currently reports 73 against 71 in Uzbekistan, a difference of 2.
The two have swapped places 1 time across 8 shared years of data; in 2012 it was India ahead.
India ranks 33rd and Uzbekistan ranks 35th of 82 countries.
Uzbekistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.17 | 47.33 | 9.17 | Uzbekistan |
| 2020s | 66.5 | 69.5 | 3 | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, India or Uzbekistan?
- India, at 73 against 71 in Uzbekistan as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between India and Uzbekistan?
- 2, with India ahead.
- How many years of comparable data are there for India and Uzbekistan?
- 8 years are reported by both, from 2012 to 2021.
- How do India and Uzbekistan rank globally for treatment success rate: xdr-tb cases?
- India ranks 33rd and Uzbekistan ranks 35th of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.